Assuming Mayo stopped enrollment because Geron is going to begin a randomized Phase 2 (an entire new large scale trial), why would Mayo stop enrollment for broader study, yet keep the study open to enroll 2-4 more patients? GERN
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.